Prenetics Global Limited

Informe acción NasdaqGM:PRE

Capitalización de mercado: US$54.0m

Prenetics Global Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Danny Yeung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO12.9%
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva1.2yrs

Actualizaciones recientes de la dirección

Recent updates

Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Oct 12
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

May 29
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Apr 08
Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Jan 07
Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M

Sep 09

CEO

Danny Yeung (45 yo)

no data

Permanencia

Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chairperson & Chief Executive Officer at Prenetics Global Limited. He served as Founding Partner at SXE Ventures. Mr. Yeung is a serial entrep...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Sheng Wu Yeung
Co-Founderno datasin datos12.94%
$ 7.0m
Chi Hung Tzang
Co-Founder & Chief Scientific Officer10.8yrssin datos4.4%
$ 2.4m
Hoi Chun Lo
Chief Financial Officer6.8yrssin datos1.33%
$ 718.8k
Samantha Kwok
Chief of Staff to Group CEO & Vice President of People & Operations1.8yrssin datossin datos
Yung Ho Wong
Chief Technology Officerno datasin datossin datos
Senthil Sundaram
Chief Clinical Officerno datasin datossin datos
Joel Neoh
Chief Consumer Officer & CEO for CircleDNA1.4yrssin datossin datos
Walt Ling
Chief Executive Officer of ACT Genomics1.8yrssin datossin datos

1.8yrs

Permanencia media

43.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de PRE no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Sheng Wu Yeung
Co-Founderno datasin datos12.94%
$ 7.0m
Pasi Antero Janne
Member of Scientific Advisory Board1.7yrssin datossin datos
Kathryn Henry
Independent Directorless than a yearsin datossin datos
Wing Kwan Chiu
Independent Directorno datasin datossin datos
David L. Katz
Member of Scientific & Medical Advisory Boardno datasin datossin datos
Shu Kam Mok
Chairman of Scientific Advisory Board1.7yrssin datossin datos
Yin Pan Cheng
Independent Directorno datasin datossin datos
David Vanderveen
Independent Directorless than a yearsin datossin datos
Suzanne Devkota
Member of Scientific & Medical Advisory Boardno datasin datossin datos
Pan-Chyr Yang
Member of Scientific Advisory Board1.7yrssin datossin datos
James L. Green
Member of Scientific Advisory Boardless than a yearsin datossin datos
Dawn Mussallem
Member of Scientific & Medical Advisory Boardno datasin datossin datos

1.2yrs

Permanencia media

55yo

Promedio de edad

Junta con experiencia: La junta directiva de PRE no se considera experimentada (1.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.